Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Learn from Change-Making Pharmaceutical Leaders: CPhI North America Keynote Speakers Announced

CPhI 2017 Event Logo

News provided by

CPhI

Apr 24, 2017, 10:24 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, April 24, 2017 /PRNewswire/ -- The world's largest pharmaceutical event series, CPhI, will debut in Philadelphia May 16–18, 2017. Leveraging the strength of the CPhI brand and adjacency to the leading fine and specialty chemical event, InformEx, CPhI North America will feature the first-ever Connect Conference. In addition to more than 44 sessions delivered by more than 55 speakers, the Connect Conference program will feature distinguished keynote presentations addressing some of the most pressing challenges and opportunities the pharmaceutical industry has before it.

CPhI North America Keynote Speaker - Ronald T. Piervincenzi, Ph.D., CEO, United States Pharmacopeial Convention (USP)
CPhI North America Keynote Speaker - Ronald T. Piervincenzi, Ph.D., CEO, United States Pharmacopeial Convention (USP)
CPhI North America Keynote Speaker - Magid Abou-Gharbia Moulder, Ph.D., FRSC Center for Drug Discovery, School of Pharmacy, Temple University
CPhI North America Keynote Speaker - Magid Abou-Gharbia Moulder, Ph.D., FRSC Center for Drug Discovery, School of Pharmacy, Temple University
CPhI North America Keynote Speaker - Ronald T. Piervincenzi, Ph.D., CEO, United States Pharmacopeial Convention (USP) CPhI North America Keynote Speaker - Magid Abou-Gharbia Moulder, Ph.D., FRSC Center for Drug Discovery, School of Pharmacy, Temple University

CPhI North America Keynote Presentations

"Partnering for Quality: A New Era"—Ronald T. Piervincenzi, Ph.D., CEO, United States Pharmacopeial Convention (USP)

Partnerships among industry, healthcare professionals, government, and nonprofit organizations such as USP have helped to lay the foundation for high-quality medicines for decades. These critical partnerships are needed more than ever to harness expertise from diverse sources to improve global access to high-quality medicines, today and in the future. Mr. Piervincenzi will share USP's vision for this new era of quality and the work being done to advance the concept of quality as well as an understanding of the value of quality.

"Discovery of Innovative Therapeutics: Today's Realities and Tomorrow's Vision"—Magid Abou-GharbiaMoulder, Ph.D., FRSC Center for Drug Discovery, School of Pharmacy, Temple University

Today's pharmaceutical industry is experiencing unprecedented difficulty and faces enormous challenges, which include the industry's declining efficiencies, patent expirations for key drugs, fierce price competition from generics, mergers and acquisitions, high regulatory hurdles, declining innovation, and the industry's perceived tarnished image. Magid Abou-Gharbia of Temple University will address these challenges and the paradigms needed to advance them while still maintaining a commitment to drug innovation.

When asked about the value of the launch of CPhI North America, Magid Abou-Gharbia commented: "Attendees will advance their understanding of pharmaceutical industry efforts to address the major challenges they and our healthcare system are facing, while continuing the industry's commitment to innovation, reducing costs, and benefiting patients."

CPhI Connect Conference Program

Powered by the expertise of the American Chemical Society (ACS), the United States Pharmacopeia (USP), the Society of Chemical Manufacturers and Affiliates (SOCMA), and UBM's rich programming resources, CPhI's unparalleled Connect Conference program will contain four tracks: Drug Development, Quality/Regulatory, Drug Manufacturing, and Outsourcing. The program will offer perspectives on a wide assortment of pressing topics within the pharmaceutical and biopharmaceutical industries, featuring speakers such as:

  • Sunny Bhardwaj, Senior Scientist, Merck
  • Richard D. Braatz, Ph.D., Edwin R. Gilliland Professor of Chemical Engineering, Massachusetts Institute of Technology
  • David Conlon, Senior Principal Scientist, Bristol-Myers Squibb
  • Ian W. Davies, Department of Process and Analytical Chemistry, Merck Research Laboratories, Merck
  • Amy Ethier, Ph.D., Formulation Scientist, Skin Delivery, BASF Pharma Solutions
  • Robert Garbaccio, Executive Director, Merck
  • Stephen V. Hammond, Senior Director/Team Leader of the Process Analytical Sciences Group, Pfizer Global Technology
  • Antonio Hernandez-Cardoso, Senior Scientific Liaison, USP
  • Jim Lalonde, Senior Vice President of R&D, Codexis Inc.
  • D. Jeffery Liu, Ph.D., M.B.A., M.S., Director/Clinical Development Head, ID/IIDPH, R&D, GSK
  • Yihong Qiu, Oral Drug Products, Manufacturing Science & Technology, AbbVie Inc.
  • David Rabuka, Ph.D., Global Head of R&D, Chemical Biology, Catalent Biologics—West (formerly Redwood Bioscience), Catalent Pharma Solutions
  • Peter D. Senter, Ph.D., Vice President, Chemistry and Senior Distinguished Fellow, Seattle Genetics
  • Satish K. Singh, Drug Product Services, Lonza Pharma and Biotech, Lonza Ltd.
  • Arvind Srivastava, Ph.D., Research Advisor, Formulation Development, CMC Development, Eli Lilly and Company
  • Pete Stevenson, Vice President and General Manager, Pfizer CentreOne
  • Tom Wilson, Vice President, Contract Manufacturing Operations, Pfizer Global Supply and Pfizer CentreOne
  • Ron Vladyka, Director of Research & Development, Catalent Pharma Solutions

"CPhI brings together a community of healthcare stakeholders with diverse, specialized expertise and perspectives," said Ronald T. Piervincenzi, Ph.D., CEO, USP. "The collaborations facilitated by this first CPhI conference held in North America provide unique opportunities to inspire new approaches to advancing the public health mission of improving the quality of medicines and foods globally."

To view the full CPhI Connect program schedule, go to schedule.cphinorthamerica.com.

Participate in the Epicenter of Pharmaceutical Innovation

CPhI Connect participants will also have access to the sold-out expo floor, featuring more than 630 companies across the complete pharma supply chain, as well as show floor programming, networking events, and much more. With its unique blend of unprecedented global influence and the infrastructure to advance relationships between buyers and sellers, CPhI North America will provide a marketplace of solutions and ideas unlike any other.

Not yet registered for CPhI North America? Visit cphinorthamerica.com.

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain, from drug discovery to finished dosage. Through exhibitions, conferences, and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities, and expand the global market. CPhI hosts events across Europe, Asia, and now North America, and co-locates with ICSE for contract services; P-MEC for machinery, equipment, and technology; InnoPack for pharmaceutical packaging; and BioPh for biopharma. CPhI provides an online buyer and supplier directory at CPhI-Online.com.

For more information, visit: www.cphi.com.

About UBM Americas

UBM Americas, a part of UBM plc, delivers events and marketing services in the fashion technology, licensing, advanced manufacturing, automotive and powersports, healthcare, veterinary, and pharmaceutical industries, among others. Through a range of aligned interactive environments, both physical and digital, UBM Americas increases business effectiveness for customers and audiences through meaningful experiences, knowledge, and connections.

The division also includes UBM Brazil's market-leading events in construction, cargo transportation, logistics and international trade, and agricultural production; and UBM Mexico's construction, advanced manufacturing, and hospitality services shows. For more information, visit: www.ubmamericas.com

SOURCE CPhI

Related Links

http://www.cphi.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.